SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication

ConferenceSirPADNeutral

AI Analysis

Summary

SirPAD randomized trial subgroup study focusing on femoropopliteal peripheral artery disease with claudication will be presented at VIVA 2026 conference in October, featuring data from 1,252 patients.

Clinical Trial Data

Patients

1,252

Outcome Details

Subgroup study results from SirPAD randomized trial to be presented at VIVA 2026

Importance:5/10

Sentiment:

0.00

clinical trialconference presentationperipheral artery diseasefemoropoplitealclaudicationrandomized trial

Read the original article

Published by PR Newswire Pharma on September 21, 2026 8:19 AM

Read Original